PortfoliosLab logo

bluebird bio, Inc. (BLUE)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in bluebird bio, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,589 for a total return of roughly -74.11%. All prices are adjusted for splits and dividends.

BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BLUE

bluebird bio, Inc.

Popular comparisons: BLUE vs. SCHD


bluebird bio, Inc. had a return of -34.83% year-to-date (YTD) and -9.44% in the last 12 months. Over the past 10 years, bluebird bio, Inc. had an annualized return of -12.94%, while the S&P 500 had an annualized return of 9.92%, indicating that bluebird bio, Inc. did not perform as well as the benchmark.

1 month-11.91%0.19%
6 months-19.75%7.70%
1 year-9.44%-9.82%
5 years (annualized)-47.61%9.44%
10 years (annualized)-12.94%9.92%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current bluebird bio, Inc. Sharpe ratio is -0.09. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

Dividend History

bluebird bio, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the bluebird bio, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the bluebird bio, Inc. is 98.05%, recorded on May 24, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-98.05%Mar 13, 20181059May 24, 2022
-81.36%Jun 1, 2015241May 12, 2016399Dec 11, 2017640
-49.91%Jul 17, 201389Nov 19, 2013143Jun 17, 2014232
-25.15%Jun 23, 201417Jul 16, 201471Oct 24, 201488
-19.58%Jan 15, 201517Feb 9, 201517Mar 5, 201534
-19.05%Dec 12, 201723Jan 16, 20186Jan 24, 201829
-12.64%Mar 20, 20154Mar 25, 201512Apr 13, 201516
-8.03%Jan 25, 201811Feb 8, 20185Feb 15, 201816
-7.91%Nov 11, 20144Nov 14, 20146Nov 24, 201410
-7.5%Nov 25, 20144Dec 1, 20142Dec 3, 20146

Volatility Chart

Current bluebird bio, Inc. volatility is 47.09%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)